Delivery Order SPE2DB24D2205-SPE2DB24FDXAK

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Rifampin 300 mg capsules and has a ceiling value of $1,432.55. The contract is a firm fixed-price Delivery Order with a completion date of July 11, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rifampin 300 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $36,030.72 and a performance period ending on April 24, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The contract has a total ceiling value of $13,330.27 and a period of performance through August 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these essential prescription medications to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The $8,227.77 firm fixed-price contract has an ultimate completion date of August 8, 2024. Amerisourcebergen is delivering these pharmaceutical products under a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive...
This contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules to the Defense Logistics Agency (DLA). The award is a Firm Fixed Price Delivery Order valued at $5,850.40 and runs through September 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Rifampin capsules. The contract has a firm fixed price and a ceiling value of $86,447.52, with a period of performance ending on July 2, 2025. The contract is not set aside and was awarded on July 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,297.32 delivery order contract is for the supply of Rifampin 300 mg capsules, a medication used to treat various bacterial infections. The contract has an ultimate completion date of June 27, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg rifampin capsules. The $2,321.04 firm fixed price contract has an ultimate completion date of August 13, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its extensive pharmaceutical supply chain network, will provide these critical prescription medications to support military treatment...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,563,216 Rifampin 300 mg capsules. The contract has a ceiling value of $59,634.48 and a period of performance ending on January 3, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this award, which is part of...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDXAK
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rifampin 300 mg capsules. The contract has an ultimate completion date of July 18, 2024 and a ceiling value of $4,642.08. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, for providing a wide range of pharmaceutical and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs.

Generated 10/16/24, 9:13 AM